Acute effect of molsidomine on pulmonary circulation of patients with chronic obstructive pulmonary diseaseMWEPU, A. K; LAMPERT, E; FRANS, A et al.Transactions of the Zoological Society of London. 1989, Vol 37, Num 10, pp 1133-1136, issn 0084-5620, 4 p.Article

Place de l'épreuve d'exercice musculaire dans le dépistage de fumeurs asymptomatiques = Place of exercice testing to detect asymptomatic smokersFABRE, J; VARRAY, A; MERCIER, J et al.Comptes rendus des séances de la Société de biologie et de ses filiales. 1990, Vol 184, Num 5-6, pp 351-357, issn 0037-9026, 7 p.Article

The «ruler sign». A semiquantitative physical sign of chronic obstructive pulmonary diseaseRAVID, M; SCHINDLER, D; SHAPIRA, J et al.Israel journal of medical sciences. 1988, Vol 24, Num 1, pp 10-12, issn 0021-2180Article

Almitrine bismesylate bei chronisch obstruktiven Atemwegserkrankungen und bestehender Hypoxämie. Kontrollierte Doppelblindindustrie mit oraler Applikation = Almitrine bismesylate dans la bronchopneumopathie obstructive et l'hypoxémie. Etude double insu = Almitrine bismesylate in patients with chronic obstructive lung disease and hypoxemia. A controlled double-blind study with oral applicationWUTTKE, R; WICHERT, P. V.Respiration (Basel). 1985, Vol 48, Num 4, pp 285-295, issn 0025-7931Article

Chronic obstructive pulmonary disease: a behavioral perspectiveMACSWEENY, A. J; GRANT, I.Lung biology in health and disease. 1988, Vol 36, issn 0362-3181, XIV-325 pSerial Issue

En direct du 5e Symposium international de Québec sur la prévention/réadaptation cardio-respiratoire. De la recherche à la pratique : mettre la science au travail ! Actualités thérapeutiques dans la prise en charge du patient BPCO, 13-15 juin 2007Concours médical (Paris). 2007, Vol 129, Num 31-32, issn 0010-5309, 8 p., SUPConference Proceedings

La BPCO : une maladie chronique en progressionBRANDLI, Otto; RUSSI, Erich-W.BULLETIN DES MEDECINS SUISSES. 2008, Vol 89, Num 45, pp 1949-1950, issn 1661-5948, 2 p.Article

Le traitement medicamenteux des bronchopneumopathies chroniques obstructives. IV, Traitements à visée étiologiqueMUIR, J. F; BENHAMOU, D; PORTIER, F et al.Concours médical (Paris). 1991, Vol 113, Num 17, pp 1431-1433, issn 0010-5309Article

Definitions in chronic obstructive pulmonary diseasePETTY, T. L.Clinics in chest medicine. 1990, Vol 11, Num 3, pp 363-373, issn 0272-5231, 11 p.Article

Breathing exercises for the medical patient : The art and the scienceKIGIN, C.M.Physical therapy. 1990, Vol 70, Num 11, pp 700-706, issn 0031-9023Article

Inventory of nutritional status in patients with COPDSCHOLS, A; MOSTERT, R; SOETERS, P et al.Chest. 1989, Vol 96, Num 2, pp 247-249, issn 0012-3692Article

Bronchial nerves in chronic obstructive airways disease: a preliminary reportEDWARDS, C.Journal of pathology. 1989, Vol 159, Num 4, pp 287-291, issn 0022-3417, 5 p.Article

Natural history of chronic airflow obstructionBURROWS, B.Lung biology in health and disease. 1989, Vol 43, pp 99-107, issn 0362-3181, 9 p.Article

The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago COPD seriesBURROWS, B.The American review of respiratory disease. 1989, Vol 140, Num 3, pp S92-S94, issn 0003-0805, 2Article

Twenty-year trends in mortality from chronic obstructive pulmonary disease: the Honolulu Heart ProgramBLOOM MARCUS, E; BUIST, A. S; MACLEAN, C. J et al.The American review of respiratory disease. 1989, Vol 140, Num 3, pp S64-S68, issn 0003-0805, 2Article

Measuring health status in chronic airflow limitationGUYATT, G.The European respiratory journal. 1988, Vol 1, Num 6, pp 560-564, issn 0903-1936Article

Measurement technique influences the response of transfer factor (TICO) to salbutamol in patients with airflow limitationCHINN, D. J; ASKEW, J; ROWLEY, L et al.European journal of respiratory diseases. 1988, Vol 1, Num 1, pp 15-21, issn 0106-4339Article

Ingénierie et management d'un protocole destiné à effectuer un état des lieux des problèmes posés par la BCPOLANZA, Eric.2012, 83 p.Thesis

Le traitement médicamenteux des bronchopneumopathies chroniques obstructives. II, Traitements physiopathologiquesMUIR, J. F; BENHAMOU, D; PORTIER, F et al.Concours médical (Paris). 1991, Vol 113, Num 15, pp 1235-1239, issn 0010-5309Article

Pirbutérol aérosol : évaluation d'un traitement prolongé = Pirbuterol aerosol : evaluation of prolonged treatmentCLAUZEL, A. M; RIFAI, N; MICHEL, F. B et al.Revue française d'allergologie et d'immunologie clinique. 1990, Vol 30, Num 4, pp 251-255, issn 0335-7457Article

Alcohol consumption an chronic obstructive pulmonary diseaseGARSHICK, E; SEGAL, M. R; WOROBEC, T. G et al.The American review of respiratory disease. 1989, Vol 140, Num 2, pp 373-376, issn 0003-0805Article

Morbidity and mortality from chronic obstructive pulmonary diseaseMANFREDA, J; YANG MAO; LITVEN, W et al.The American review of respiratory disease. 1989, Vol 140, Num 3, pp S19-S26, issn 0003-0805, 2Article

The changes in airways structure associated with reduced forced expiratory volume in one secondMATSUBA, K; WRIGHT, J. L; WIGGS, B. R et al.The European respiratory journal. 1989, Vol 2, Num 9, pp 834-839, issn 0903-1936, 6 p.Article

The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trialKULLER, L. H; OCKENE, J. K; TOWNSEND, M et al.The American review of respiratory disease. 1989, Vol 140, Num 3, pp S76-S81, issn 0003-0805, 2Article

Value of two-dimensional echocardiograhy in the identification of pulmonary hypertension in chornic obstructive lung diseaseBERTOLI, L; MANTERO, A; ALPAGO, R et al.Respiration (Basel). 1989, Vol 55, Num 4, pp 193-201, issn 0025-7931, 9 p.Article